Airing weekdays at 7:30 A.M. on

Airing weekdays at 7:30 A.M. on

Chondrosarcoma is a rare bone cancer that causes tumors to grow in the cartilage of the pelvis, long bones, ribs, scapula, and vertebrae. Symptoms include swelling at the site of the tumor, pain, and decreased range of motion. There are no effective treatment options for people with unresectable or metastatic chondrosarcoma despite many attempts by multiple pharmaceutical companies over the past few decades.

Inhibrx, a clinical-stage biotechnology company, is dedicated to helping people with life-threatening conditions. They are developing a therapeutic option for chondrosarcoma called INBRX-109, which is currently in clinical trials.

Stay tuned to meet with Dr. Sant Chawla of Sarcoma Oncology Center to learn more, and speak with one patient who is a chondrosarcoma survivor. Speak to your doctor to learn if a clinical trial may be right for you.

Mixing it up in sweet and savory ways: We’re featuring the world-famous, award-winning Angostura® aromatic bitters, orange bitters, and the newly introduced cocoa bitters.

Multiple sclerosis (MS) is an autoimmune condition where the immune system inappropriately attacks the brain and the spinal cord.

What women "auto" know about car insurance, plus living with and managing multiple sclerosis, and mixing it up with Angostura coca bitters.

Comments

comments